Table 4.
Baseline to 12-month changes in clinical variables for KLD and ULF.
| KLD | ULF | p-value | |
|---|---|---|---|
| Weight (kg)a | -9.9 (-12.9, -6.9) | -10.5 (-13.3, -7.6) | 0.78 |
| HDL (mg/dl) | 4.9 (1.3, 8.5) | 0.1 (-3.3, 3.5) | 0.05 |
| LDL (mg/dl) | 5.0 (-6.7, 16.7) | -3.3 (-14.1, 7.6) | 0.31 |
| Trig (mg/dl) | -113.7 (-191.2, -36.2) | -13.0 (-85.7, 59.7) | 0.06 |
| Log TG/HDL ratio | -0.62 (-0.87, -0.37) | -0.09 (-0.32, 0.15) | <0.01 |
| HOMA-IR | -1.3 (-2.3, -0.30) | -1.6 (-2.5, -0.6) | 0.67 |
| Sugar (%calories) | -16.6 (-22.2, -11.1) | -1.1 (-6.2, 4.0) | <0.001 |
| Total sugars (g) | -57.9 (-78.6, -37.1) | -10.8 (-29.9, 8.4) | 0.001 |
a
p-values, estimates, and 95% confidence intervals from a linear mixed effects model including fixed effects for time, diet, and time*diet interaction, and a random effect for study participant.